Evidence map›Paper›PMID 37600976›Full record

ReviewTherapeutic advances in infectious disease

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy.

Tanner M Johnson, Leah C Whitman Webster, Meera Mehta, Jessica E Johnson, Nicolás Cortés-Penfield, Christina G Rivera

Abstract readReview
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tanner M JohnsonDepartment of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-9181-8347
Leah C Whitman WebsterDepartment of Pharmacy, Mayo Clinic, Jacksonville, FL, USA.
Meera MehtaWest Virginia University Hospitals, Morgantown, WV, USA.
Jessica E JohnsonDepartment of Medicine, Section of Infectious Diseases, West Virginia University, Morgantown, WV, USA.
Nicolás Cortés-PenfieldDivision of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Christina G RiveraDepartment of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravenous push (IVP) antimicrobial administration refers to rapid bolus infusion of medication. This drug delivery method offers improved patient convenience, superior patient and nursing satisfaction, and cost savings when used in outpatient parenteral antimicrobial therapy (OPAT). Antimicrobial agents must demonstrate optimal physiochemical and pharmacologic characteristics, as well as sufficient syringe stability, to be administered in this manner. Additionally, impacts on medication tolerability, patient safety, and effectiveness must be considered. This narrative review summarizes the available data and practical implications of IVP administration of antimicrobials in the OPAT setting.

Indexed as

administrationantibioticsantimicrobialsinfusionintravenous pushOPAT

Identifiers

PMID37600976
PMCPMC10434178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.